The purpose of this study is to investigate cancer cachexia in patients with colorectal, lung, or pancreatic cancer. This study evaluates different aspects of cancer cachexia, including symptoms, physical function, and blood markers. Researchers investigate the various subtypes of this condition to improve diagnostic criteria and treatment strategies.
- Who can participate: Adults aged 18 and older with unresectable or stage IV non-small cell lung cancer, pancreatic adenocarcinoma, or colorectal cancer can participate. They must be starting or have recently started first-line systemic anti-cancer therapy and have an ECOG performance status of 0 to 2. Participants need to understand and speak English.
- Study details: Participants will complete surveys, undergo physical tests, and provide blood and tumor samples. Some will wear a device to track activity. No placebo is involved in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand